Voloridge Investment Management, LLC Vir Biotechnology, Inc. Transaction History
Voloridge Investment Management, LLC
- $25.9 Billion
- Q4 2024
A detailed history of Voloridge Investment Management, LLC transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Voloridge Investment Management, LLC holds 769,725 shares of VIR stock, worth $4.23 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
769,725
Previous 975,300
21.08%
Holding current value
$4.23 Million
Previous $7.3 Million
22.66%
% of portfolio
0.02%
Previous 0.03%
Shares
12 transactions
Others Institutions Holding VIR
# of Institutions
233Shares Held
90.1MCall Options Held
1.28MPut Options Held
235K-
Sb Investment Advisers (Uk) LTD London, X016.7MShares$91.8 Million1.08% of portfolio
-
Black Rock Inc. New York, NY16.4MShares$90.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.1MShares$72.2 Million0.0% of portfolio
-
State Street Corp Boston, MA5.07MShares$27.9 Million0.0% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.22MShares$17.7 Million0.64% of portfolio
About Vir Biotechnology, Inc.
- Ticker VIR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 132,638,000
- Market Cap $730M
- Description
- Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...